Metraipolis › archive › dc_ac861fc2884e

Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42518007
DOI
10.1007/s10787-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-17T14:13:43.724Z
SHA-256 of the archived text
db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd
Stable URL of this page
https://metraipolis.com/documento/dc_ac861fc2884e

How to cite

Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007 — Europe PMC (en), https://europepmc.org/article/MED/42518007 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac861fc2884e (Metraipolis archive dc_ac861fc2884e, sha256 db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd)
BibTeX
@misc{dcac861fc2884e,
  title = {Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination — Europe PMC PMID:42518007},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42518007},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac861fc2884e; sha256 db371bb537153afb86e9142c3862fdbf6cdce72dd101ee6514368dd4b7c9e4dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42518007. Agents can read the archived copy with the MCP tool read_document.